Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

News

  • Home
  •  
  • News



  • Most Read
  • Latest Comments
  • Silicon Valley Bank fiasco: Dubber exposed at over $1 million as it attempts to recover from ongoing losses
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Silicon Valley Bank fiasco: Dubber exposed at over $1 million as it attempts to recover from ongoing losses
    • News

    Smart pain assessment app now used by more than half of Australia’s residential aged care providers
    Public
  • Silicon Valley Bank fiasco: Dubber exposed at over $1 million as it attempts to recover from ongoing losses
    • News

    Fledgling fintech hopes millennials put their Douugh into micro-investing ‘super’ app
    Public
  • Silicon Valley Bank fiasco: Dubber exposed at over $1 million as it attempts to recover from ongoing losses
    • News

    🎵 The knee bone’s connected to the… collagen rope device (?!)
    Public
  • Silicon Valley Bank fiasco: Dubber exposed at over $1 million as it attempts to recover from ongoing losses
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial
    • Review
    • September 1, 2022

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • Crowd Media enters the Metaverse with digital real estate purchase
    • News

    Crowd Media enters the Metaverse with digital real estate purchase

    With public interest in digital worlds accelerated by the transition from Facebook to Meta and the upcoming launch of their Metaverse, artificial intelligence company Crowd Media (ASX: CM8) has given a glimpse into its plans within these digital worlds. Unlike others that are just coming to the party in the form of virtual reality tech,

    Read More
    Public
  • BikeExchange to offer fully-built bikes delivered from online sales via Kitzuma acquisition
    • News

    BikeExchange to offer fully-built bikes delivered from online sales via Kitzuma acquisition

    Online bicycle marketplace operator BikeExchange (ASX: BEX) is addressing one of the biggest pain points to buying a bike online, by offering them fully built without the need to put it together from a box via their acquisition of delivery and logistics company Kitzuma. As a growing business that services all major regions of North

    Read More
    Public
  • Creating a culture of wellbeing to become an employer of choice
    • News

    Creating a culture of wellbeing to become an employer of choice

    Whilst they might have just been acquired by fintech giant HUB24 (ASX: HUB) things haven’t changed at Class (ASX: CL1) with regard to their people and culture.  Investing in people has always been a priority for the tech company, especially given the so called ‘war on talent’ that has hiring managers and HR staff pulling

    Read More
    Public
  • Special delivery: unique drug delivery system receives new US patent
    • News

    Special delivery: unique drug delivery system receives new US patent

    Let’s rewind to Year 10 biology- you know that mitochondria is the powerhouse of the cell, chances are you vaguely remember the golgi apparatus but do you remember what an exosome is? Exosomes, or extracellular vesicles are little packages delivering molecules and enhancing cell-to-cell communication. Clinical- stage biopharmaceutical company Exopharm (ASX: EX1) is utilising exosomes

    Read More
    Public
  • Marley Spoon emerges as winner of meal delivery stakes with acquisition of Chefgood
    • News

    Marley Spoon emerges as winner of meal delivery stakes with acquisition of Chefgood

    Having ridden out the surge in demand for meal delivery services brought upon by the pandemic, Marley Spoon (ASX: MMM) is set to be one of the few brands that will maintain that momentum in the post-COVID world with the sector poised to undergo a period of consolidation.  Demand for such services was first accelerated

    Read More
    Public
  • Nine fights back against streaming services, extends NRL broadcast deal by 5 years for $650m
    • News

    Nine fights back against streaming services, extends NRL broadcast deal by 5 years for $650m

    If there’s one thing the NRL can do that the AFL cannot, it is maintain just one partner – in broadcasting terms at least. The 30 year marriage will continue at least to the end of 2027 with the National Rugby League (NRL) agreeing to terms with Nine Entertainment (ASX: NEC) for a 5-year extension

    Read More
    Public
  • Stuck in line waiting for a COVID test? This company is loving the 4+ hour wait times
    • News

    Stuck in line waiting for a COVID test? This company is loving the 4+ hour wait times

    Perhaps the displeasure of waiting in line for hours to get a COVID test this holiday season would be slightly allayed if you were a shareholder in a pathology company doing the leg work? Investors who saw the value in pathology and ‘pro-pandemic’ stocks like Australian Clinical Labs (ASX: ACL) will be glad to read

    Read More
    Public
  • Queensland Revenue Office engages SenSen for mobile number plate scanning
    • News

    Queensland Revenue Office engages SenSen for mobile number plate scanning

    Work smarter, not harder. That’s exactly what the Queensland State Revenue Office is going to do going forward as the State increases its smart city capabilities, having engaged tech company SenSen Networks (ASX: SNS) for mobile number plate scanning. The engagement will be for 3 years and is valued at a minimum of $192,000 to

    Read More
    Public
  • Shareholders back Pharmaxis liver cancer treatment trials via oversubscribed capital raise
    • News

    Shareholders back Pharmaxis liver cancer treatment trials via oversubscribed capital raise

    When the University of Rochester came knocking on the door of biopharmaceutical company Pharmaxis (ASX: PXS), it was a boost from a respected group of researchers for their lead drug candidate PXS-5505 which has continued to draw attention from around the world.  By agreement with Pharmaxis, the University of Rochester embarked on preclinical work on 

    Read More
    Public
  • Concussion tech company bringing product to grassroots athletes
    • News

    Concussion tech company bringing product to grassroots athletes

    Take it from me- concussions are awful. There’s unrelenting dizziness, nausea and that foggy brain feeling, if you’re lucky. Those who fare worse can be left with permanent issues with balance, mood, memory and cognition.  A major cause of concussion is sport, where concussion management technology company HITIQ (ASX: HIQ) is working to reduce its

    Read More
    Public
  • «
  • ‹
  • 204
  • 205
  • 206
  • 207
  • 208
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.